COVID-19 second-generation vaccine research
Support second-generation COVID-19 vaccine research at Burnet.
Support COVID-19 second-generation vaccine research at Burnet.
Support second-generation COVID-19 vaccine research at Burnet.
Support COVID-19 second-generation vaccine research at Burnet.
Burnet Institute is working towards the achievement of the World Health Organization’s (WHO) hepatitis B elimination targets in Australia and globally.
The WHO estimated that 257 million people were living with chronic HBV infection in 2015 and that hepatitis B results in 887 000 deaths every year worldwide.
These policy briefs are designed to explain key findings of our work clearly and provide recommendations for government, community organisations and policymakers alike.
To download a report, click on the title of the report below:
Deputy Director (Programs); Adjunct Professor, Monash University, DEPM.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2021 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
